Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty is being promoted to the newly created position of Chief Strategy Officer Marco Angelone is being promoted to the role of Chief Financial Officer

Emigsville, Pa: Herculite Products Inc., a leading innovator and manufacturer of high-performance and custom fabrics are pleased to announce that Paul Flaherty and Marco Angelone have received leadership promotions.

Paul Flaherty is being promoted to the newly created position of Chief Strategy Officer. In this new role, Paul will be responsible for the development and implementation of the company’s long-range strategic initiatives.

Paul Flaherty is a CPA who earned his bachelor’s degree from Duquesne University and his master’s degree from Mount St Mary’s University. He has been with Herculite for 10 years serving as the Chief Financial Officer. Prior to coming to Herculite, he served as the CFO of several local companies.

Marco Angelone is being promoted to the role of Chief Financial Officer to fill Paul’s vacancy. Marco is a CPA who earned his bachelor’s degree from Kutztown University. He has been with Herculite for two years in his role as Controller. Prior to coming to Herculite, he spent six years at RKL as the Audit Manager.

Both positions will report to President and CEO, Peter McKernan. Marco and Paul will continue to provide leadership and strategic vision to Herculite as we continue to invest and expand our operations and capabilities to better serve our customer-partners.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.